bioRxiv Science⌕ Search

Biology subjects

Palomino, M.

Publications and source records attributed to Palomino, M..

2 recordsLinked to original sources

Evidence for the extinction burst in grip force: A preregistered study

In behavioral science, "extinction" refers to the change that results when a previously rewarded pursuit no longer yields reward; accordingly, this phenomenon is central to behavioral reorganization across species. Although one might expect a monotonic transition from engagement to disengagement in goal-directed behavior, in mammals this transition is often non-monotonic whereby behavior can transiently intensify before ceasing to occur--a phenomenon known as the "extinction burst." Detecting this effect requires a metric and time window that capture the sometimes short-lived performance increase and enable comparison to counterfactual continued-reward trajectories. Certifying an increase as genuine behavioral intensification further requires ruling out increases attributable to release from competition with reward-consummatory activities, as well as inflation of peak values by extinction-induced variability. We preregistered a study in which participants earned money by squeezing a hand dynamometer. Peak standardized force in short, time-matched blocks was pre-specified as the primary index; analyses contrasted before-to-after change at different tiers where extinction was present versus absent. Peak force increased upon extinction onset, yielding a large and robust stage-by-treatment interaction effect. Our symbolic reward regime precludes release-from-competition explanations. The continuous-force record further shows a genuine central-tendency increase, ruling out variance inflation as the source of the peak-force effect.

animal behavior and cognition↗

Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate

The COVID-19 pandemic has claimed the lives of millions of people worldwide and threatens to become an endemic problem, therefore the need for as many types of vaccines as possible is of high importance. Because of the millions of doses required, it is desirable that vaccines are not only safe and effective, but also easy to administer, store, and inexpensive to produce. Newcastle Disease Virus (NDV) is responsible for a respiratory disease in chickens. It has no pathogenic homologue in humans. NDV is recognized as an oncolytic virus, and its use in humans for oncological treatment is being evaluated. In the present work, we have developed two types of NDV-vectored candidate vaccines, which carry the surface-exposed RBD and S1 antigens of SARS-CoV-2, respectively. These vaccine candidates were produced in specific-pathogen-free embryonating chicken eggs, and purified from allantoic fluid before lyophilization. These vaccines were administered intranasally to three different animal models: mice, rats and hamsters, and evaluated for safety, toxicity, immunogenicity, stability and efficacy. Efficacy was evaluated in a challenge assay against active SARS-CoV-2 virus in the Golden Syrian hamster model. The NDV-vectored vaccine based on the S1 antigen was shown to be safe and highly immunogenic, with the ability to neutralize SARS-CoV-2 in-vitro, even with an extreme dilution of 1/640. Our results reveal that this vaccine candidate protects the lungs of the animals, preventing cellular damage in this tissue. In addition, this vaccine reduces the viral load in the lungs, suggesting that it may significantly reduce the likelihood of transmission. Being lyophilized, this vaccine candidate is very stable and can be stored for several months at 4-8C. In conclusion, our NDV-based vaccine candidate has shown a very favorable performance in the pre-clinical study, serving as evidence for a future evaluation in a Phase-I human clinical trial. This candidate represents a promising tool in the fight against COVID-19.

immunology↗